Fjarde Ap-fonden’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-197,516
| Closed | -$19.6M | – | 634 |
|
|
2019
Q3 | $19.6M | Sell |
197,516
-1,000
| -0.5% | -$95K | 0.26% | 86 |
|
|
2019
Q2 | $18.4M | Sell |
198,516
-3,500
| -2% | -$332K | 0.24% | 92 |
|
|
2019
Q1 | $19.1M | Buy |
202,016
+37,776
| +23% | +$3.3M | 0.24% | 87 |
|
|
2018
Q4 | $10.5M | Sell |
164,240
-28,800
| -15% | -$2.13M | 0.18% | 112 |
|
|
2018
Q3 | $17.3M | Sell |
193,040
-17,263
| -8% | -$1.53M | 0.25% | 83 |
|
|
2018
Q2 | $16.7M | Sell |
210,303
-10,562
| -5% | -$877K | 0.25% | 87 |
|
|
2018
Q1 | $19.7M | Buy |
220,865
+4,276
| +2% | +$410K | 0.3% | 70 |
|
|
2017
Q4 | $22.6M | Buy |
216,589
+33,351
| +18% | +$3.76M | 0.34% | 63 |
|
|
2017
Q3 | $26.7M | Buy |
183,238
+4,037
| +2% | +$550K | 0.51% | 38 |
|
|
2017
Q2 | $23.3M | Buy |
179,201
+24,030
| +15% | +$2.94M | 0.47% | 38 |
|
|
2017
Q1 | $19.3M | Sell |
155,171
-11,094
| -7% | -$1.33M | 0.46% | 40 |
|
|
2016
Q4 | $19.2M | Sell |
166,265
-16,442
| -9% | -$1.83M | 0.45% | 44 |
|
|
2016
Q3 | $19.1M | Buy |
182,707
+3,144
| +2% | +$340K | 0.42% | 46 |
|
|
2016
Q2 | $17.7M | Buy |
179,563
+941
| +0.5% | +$97.3K | 0.41% | 50 |
|
|
2016
Q1 | $17.9M | Buy |
178,622
+21,932
| +14% | +$2.26M | 0.41% | 50 |
|
|
2015
Q4 | $18.8M | Sell |
156,690
-564
| -0.4% | -$65.3K | 0.49% | 43 |
|
|
2015
Q3 | $17M | Sell |
157,254
-12,538
| -7% | -$1.56M | 0.47% | 47 |
|
|
2015
Q2 | $19.7M | Sell |
169,792
-9,853
| -5% | -$1.13M | 0.47% | 46 |
|
|
2015
Q1 | $20.7M | Sell |
179,645
-10,703
| -6% | -$1.28M | 0.48% | 48 |
|
|
2014
Q4 | $21.3M | Sell |
190,348
-13,679
| -7% | -$1.44M | 0.46% | 44 |
|
|
2014
Q3 | $19.3M | Sell |
204,027
-18,899
| -8% | -$1.71M | 0.41% | 50 |
|
|
2014
Q2 | $19.1M | Sell |
222,926
-16,380
| -7% | -$1.25M | 0.38% | 54 |
|
|
2014
Q1 | $16.7M | Buy |
239,306
+10,296
| +4% | +$815K | 0.33% | 70 |
|
|
2013
Q4 | $19.3M | Sell |
229,010
-17,836
| -7% | -$1.41M | 0.4% | 53 |
|
|
2013
Q3 | $19M | Sell |
246,846
-18,794
| -7% | -$1.32M | 0.41% | 54 |
|
|
2013
Q2 | $15.5M | Buy |
+265,640
| New | +$16M | 0.32% | 66 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
Fjarde Ap-fonden's CELG Position: Q4 2019 in Review
Fjarde Ap-fonden sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 197,516 shares — an estimated $19.6M sold.
Fjarde Ap-fonden first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $26.7M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Fjarde Ap-fonden reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Fjarde Ap-fonden sold 197,516 Celgene Corp shares in Q4 2019, an estimated $19.6M.
- Fjarde Ap-fonden first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
- Fjarde Ap-fonden's Celgene Corp position peaked at $26.7M in Q3 2017.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Fjarde Ap-fonden's 13F filing for Q4 2019, filed 10 Feb 2020.